African Drug Importer Accused Of $1.2B Ponzi Scheme

Law360, New York (June 11, 2009, 12:00 AM EDT) -- Authorities in South Africa are investigating allegations that a pharmaceutical ingredient import business was a Ponzi scheme that defrauded investors around the world of up to $1.2 billion.

South Africa's The Mercury newspaper reported that investigators believe Barry Tannenbaum, a South African businessman living in Australia, promised investors up to 200 percent returns linked to pharmaceutical imports, but was actually paying early investors with funds from new clients.

A private security firm hired by investors to investigate the scheme has estimated that 200 investors in the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.